Detection of diuretic agents in doping control

Journal of Chromatography. B, Biomedical Applications
R Ventura, J Segura

Abstract

Since the inclusion of diuretics in the list of banned substances in sports in 1988, a large number of screening and confirmation procedures to detect the presence of these substances in urine samples have been developed. In this paper, a review of the analytical methodology described to analyze diuretics is presented. The paper has been focused on the needs of doping control and mainly screening procedures including sample preparation and liquid or gas chromatographic separation have been considered. More relevant papers using capillary zone electrophoresis have been also considered. Mass spectrometry is mandatory in doping control for confirmation purposes, and finally, mass spectrometric techniques described for diuretics have been reviewed.

References

Jul 1, 1979·Clinical Pharmacokinetics·R E Cutler, A D Blair
Feb 19, 1979·European Journal of Clinical Pharmacology·H L FleurenJ M van Rossum
Mar 1, 1979·Journal of Pharmaceutical Sciences·C SchmittB Plazonnet
Aug 1, 1979·European Journal of Clinical Pharmacology·U Gundert-RemyE Mutschler
Dec 2, 1977·European Journal of Clinical Pharmacology·B Beermann, M Groschinsky-Grind
Dec 16, 1977·European Journal of Clinical Pharmacology·W RiessM Zimmerli
May 1, 1978·Journal of Pharmaceutical Sciences·E RedalieuW E Wagner
Aug 1, 1977·Clinical Pharmacology and Therapeutics·S C HalladayD E Carter
Oct 1, 1977·Clinical Pharmacology and Therapeutics·B BeermannB Lindström
Dec 1, 1977·Journal of Pharmaceutical Sciences·H LiD Mufson
Dec 29, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·U AbshagenG Luszpinski
Aug 1, 1975·Journal of Pharmaceutical Sciences·W J VandenheuvelF J Wolf
Feb 1, 1976·Clinical Pharmacology and Therapeutics·A KarimM Dooley
Feb 1, 1976·Clinical Pharmacology and Therapeutics·A KarimB J Baltes
May 1, 1976·Clinical Pharmacology and Therapeutics·B BeermannA Rosén
Nov 6, 1992·Journal of Chromatography·E Bonet DomingoM C García Alvarez-Coque
May 1, 1992·Journal of Analytical Toxicology·H W Hagedorn, R Schulz
May 1, 1992·Rapid Communications in Mass Spectrometry : RCM·J D Ehrhardt
Jan 1, 1991·Journal of Pharmaceutical and Biomedical Analysis·F Y TsaiB Chang
Jan 1, 1991·Journal of Pharmaceutical and Biomedical Analysis·F T Delbeke, M Debackere
May 1, 1990·Clinical Pharmacokinetics·L L Ponto, R D Schoenwald
Mar 1, 1990·Journal of Analytical Toxicology·J ParkM J Choi
Mar 1, 1990·Journal of Analytical Toxicology·S J ParkJ Park
Mar 1, 1990·Journal of Analytical Toxicology·C N YoonJ Park
Jul 1, 1987·Sports Medicine·J E Caldwell
Mar 1, 1988·Biopharmaceutics & Drug Disposition·F T Delbeke, M Debackere
Apr 10, 1987·Journal of Chromatography·R O FullinfawR F Moulds
Nov 1, 1986·Biopharmaceutics & Drug Disposition·P G Welling
Mar 1, 1985·British Journal of Clinical Pharmacology·D J ChapronP A Kramer

❮ Previous
Next ❯

Citations

Mar 7, 2013·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Irena BaranowskaJacek Baranowski
May 16, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·J Caslavska, W Thormann
Mar 12, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·C JiménezJ Segura
Jul 31, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Y QinS Q Peng
Jul 20, 2010·Annual Review of Analytical Chemistry·Larry D Bowers
Nov 19, 2010·Bioanalysis·María Jose Ruiz-ÁngelMaria Celia García-Álvarez-Coque
Jun 7, 2008·Journal of Chromatography. a·Heli SirénMarja-Liisa Riekkola
Jun 26, 2007·Journal of Chromatography. a·S Pous-TorresM C García-Alvarez-Coque
Apr 12, 2006·Journal of Separation Science·Xiuhan YangXiangmin Zhang
Aug 5, 2006·Mass Spectrometry Reviews·Mario Thevis, Wilhelm Schänzer
Mar 21, 2007·Electrophoresis·Minghua LuGuonan Chen
Sep 25, 2002·Journal of Mass Spectrometry : JMS·Patrice GarciaJean Claude Tabet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.